People: Transition Therapeutics Inc (TTH.TO)
Mr. Carl Damiani is President, Chief Operating Officer of the Company. He was Vice President - Business Development of Transition Therapeutics Inc. Mr. Damiani is a key member of the Company's management team and is responsible for a broad range of activities, including licensing and intellectual property strategies. Prior to joining Transition, Mr. Damiani led multiple successful start-up businesses in the biotech and services industries.
|Total Annual Compensation, CAD||199,228|
|Restricted Stock Awards, CAD||--|
|Long-Term Incentive Plans, CAD||--|
|All Other, CAD||--|
|Fiscal Year Total, CAD||199,228|